Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And

See also
Status	Clinical Trial	Phase
Completed	`NCT04267380` - A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day
Completed	`NCT04267614` - This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
Completed	`NCT05932433` - Effectiveness of Therapeutic Exercise on the Gut Microbiome in Chronic Widespread Pain Patients.	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04267380 - A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

Completed

NCT04267614 - This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

Completed

NCT05932433 - Effectiveness of Therapeutic Exercise on the Gut Microbiome in Chronic Widespread Pain Patients.

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04721821
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	January 22, 2021
Completion date	November 29, 2021

Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms